Biolife Solutions (BLFS) Non Operating Interest Expenses (2010 - 2021)

Biolife Solutions (BLFS) has reported Non Operating Interest Expenses for 11 consecutive years, with $7000.0 the latest figure, recorded in Q3 2021.

• On a quarterly basis, Non Operating Interest Expenses rose 40.0% year-over-year to $7000.0 in Q3 2021; TTM through Sep 2021 was -$2000.0, a 122.22% decrease from a year earlier, with the FY2019 full-year figure at $13000.0, up 160.0% from the prior year.
• Non Operating Interest Expenses was $7000.0 for Q3 2021 at Biolife Solutions, up from -$9000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $104582.0 in Q2 2017 and troughed at -$9000.0 in Q4 2020.
• A 5-year average of $16461.5 and a median of $1077.0 in 2017 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 99.04% in 2018 and jumped 1200.0% in 2019, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $1008.0 in 2017, then retreated by 0.79% to $1000.0 in 2018, then jumped by 1200.0% to $13000.0 in 2019, then tumbled by 169.23% to -$9000.0 in 2020, then surged by 177.78% to $7000.0 in 2021.
• The last three Non Operating Interest Expenses figures came in at $7000.0 (Q3 2021), -$9000.0 (Q4 2020), and $5000.0 (Q3 2020), per Business Quant data.